These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 3541576

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic.
    Stokol T, Erb HN, De Wilde L, Tornquist SJ, Brooks M.
    Vet Clin Pathol; 2005 Dec; 34(4):375-82. PubMed ID: 16270263
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
    Saito M, Asakura H, Jokaji H, Uotanzi C, Kumabashiri I, Yoshida T, Hashizume K, Matsuda T.
    Acta Haematol; 1990 Dec; 84(3):149-55. PubMed ID: 2123066
    [Abstract] [Full Text] [Related]

  • 5. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
    Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN.
    Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
    [Abstract] [Full Text] [Related]

  • 6. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K, Wada H, Abe Y, Tomatsu H, Nishioka J, Nobori T.
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N, Kagiya H, Kumagai T, Kameko M, Tozuka M, Saito H, Katsuyama T, Kanai M.
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
    Madoiwa S, Kitajima I, Ohmori T, Sakata Y, Mimuro J.
    Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
    [Abstract] [Full Text] [Related]

  • 15. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation.
    Stokol T, Brooks MB, Erb HN, Mauldin GE.
    Am J Vet Res; 2000 Apr; 61(4):393-8. PubMed ID: 10772103
    [Abstract] [Full Text] [Related]

  • 16. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
    Song KS, Kim YA, Kim HK, Park Q.
    Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.